Home Boronic Acids 1799612-11-5
1799612-11-5,MFCD30728469
Catalog No.:AA00ATCZ

1799612-11-5 | 1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$62.00   $43.00
- +
1g
95%
in stock  
$245.00   $171.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00ATCZ
Chemical Name:
1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine
CAS Number:
1799612-11-5
Molecular Formula:
C20H32BClN2O3
Molecular Weight:
394.7437
MDL Number:
MFCD30728469
SMILES:
CN1CCN(CC1)CCOc1ccc(c(c1Cl)C)B1OC(C(O1)(C)C)(C)C
Properties

Downstream Synthesis Route

[1]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2015/97123,2015,A1

[2]CurrentPatentAssignee:SERVIERMONDE-WO2016/207216,2016,A1

[3]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2016/207217,2016,A1

[4]CurrentPatentAssignee:SERVIERMONDE-WO2016/207226,2016,A1

[5]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;SERVIERMONDE-WO2017/125224,2017,A1

[6]CurrentPatentAssignee:PRELUDETHERAPUETICS;PRELUDETHERAPEUTICSINCORPORATED-WO2020/123994,2020,A1

[1]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2015/97123,2015,A1

[2]CurrentPatentAssignee:SERVIERMONDE-WO2016/207216,2016,A1

[3]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2016/207217,2016,A1

[4]CurrentPatentAssignee:SERVIERMONDE-WO2016/207226,2016,A1

[5]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;SERVIERMONDE-WO2017/125224,2017,A1

[6]CurrentPatentAssignee:BIRDOTECH-CN107573360,2018,A

[7]CurrentPatentAssignee:SERVIERMONDE-WO2020/78875,2020,A1

[8]CurrentPatentAssignee:SERVIERMONDE-WO2020/78875,2020,A1

[9]CurrentPatentAssignee:PRELUDETHERAPUETICS;PRELUDETHERAPEUTICSINCORPORATED-WO2020/123994,2020,A1

[10]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA;1200PHARMALLC;CALIFORNIAINSTITUTEOFTECHNOLOGY-WO2021/67827,2021,A1

[1]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2015/97123,2015,A1

[2]CurrentPatentAssignee:SERVIERMONDE-WO2016/207216,2016,A1

[3]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2016/207217,2016,A1

[4]CurrentPatentAssignee:SERVIERMONDE-WO2016/207226,2016,A1

[5]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;SERVIERMONDE-WO2017/125224,2017,A1

[6]CurrentPatentAssignee:PRELUDETHERAPUETICS;PRELUDETHERAPEUTICSINCORPORATED-WO2020/123994,2020,A1

5464-12-0   
2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol 
 
1-(2-(2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)phenoxy)ethyl)-4-methylpiperazine 

[1]Patent:WO2015/97123,2015,A1.Locationinpatent:Page/Pagecolumn69;70

[2]Patent:WO2016/207226,2016,A1.Locationinpatent:Page/Pagecolumn68

[3]Patent:WO2016/207216,2016,A1.Locationinpatent:Page/Pagecolumn33;37

[4]Patent:WO2016/207217,2016,A1.Locationinpatent:Page/Pagecolumn48-49

[5]Patent:WO2017/125224,2017,A1.Locationinpatent:Page/Pagecolumn32

[1]CurrentPatentAssignee:SERVIERMONDE;LIGANDPHARMACEUTICALSINC-WO2015/97123,2015,A1

[2]CurrentPatentAssignee:SERVIERMONDE-WO2016/207226,2016,A1

[3]Szlavik,Zoltan;Csekei,Marton;Paczal,Attila;Szabo,ZoltanB.;Sipos,Szabolcs;Radics,Gabor;Proszenyak,Agnes;Balint,Balazs;Murray,James;Davidson,James;Chen,Ijen;Dokurno,Pawel;Surgenor,AllanE;Daniels,ZoeMarie;Hubbard,RoderickE.;LeToumelin-Braizat,Gaëtane;Claperon,Audrey;Lysiak-Auvity,Gaëlle;Girard,Anne-Marie;Bruno,Alain;Chanrion,Maia;Colland,Frédéric;Maragno,Ana-Leticia;Demarles,Didier;Geneste,Olivier;Kotschy,Andras[JournalofMedicinalChemistry,2020,vol.63,#22,p.13762-13795]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1799612-11-5
Building Blocks
More >
Tags:1799612-11-5 Molecular Formula|1799612-11-5 MDL|1799612-11-5 SMILES|1799612-11-5 1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine